The Biotherapy Center, Tumor Hospital of Harbin Medical University, Harbin, P. R. China.
Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, P. R. China.
Cell Adh Migr. 2023 Dec;17(1):1-10. doi: 10.1080/19336918.2023.2265158. Epub 2023 Oct 9.
The aim of this study was to investigate how the concentration of interleukin-13 (IL-13) affects the regulation of endothelial cell migration after injury. The incubation of recombinant human interleukin-13 (rhIL-13) strongly increased the content of reactive oxygen species (ROS) in HUVECs via the JAK-1/STAT-3/NOX-4 signaling pathway. Antagonizing the high intracellular ROS that was induced by rhIL-13 promoted the migration of HUVECs. Furthermore, IL-13 neutralization not only inhibited intimal hyperplasia, but also promoted the migration of endothelial cells (ECs) after injury. The results suggest that IL-13 inhibition is a potential means of stimulating endothelial cells recovery after injury. Therefore, the attenuation of IL-13 activation may have therapeutic value for vascular disease.
本研究旨在探讨白细胞介素-13(IL-13)的浓度如何影响损伤后内皮细胞迁移的调节。重组人白细胞介素-13(rhIL-13)通过 JAK-1/STAT-3/NOX-4 信号通路强烈增加 HUVECs 中活性氧(ROS)的含量。拮抗 rhIL-13 诱导的高细胞内 ROS 促进了 HUVECs 的迁移。此外,IL-13 中和不仅抑制内膜增生,而且促进损伤后内皮细胞(ECs)的迁移。结果表明,IL-13 抑制是刺激损伤后内皮细胞恢复的一种潜在手段。因此,抑制 IL-13 的激活可能对血管疾病具有治疗价值。